Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
Prior Authorization Elimination: Is Optum Rx mo...
By
Rene Pretorius
March 28, 2025
Summary Optum Rx, a pharmacy benefit manager owned by UnitedHealth Group, will eliminate prior authorization elimination for about 80 drugs starting May 1, 2025. This
Systems Thinking in Pharmaceutical Access: Future-Proofing Value Strategy
Journavx Market Access Strategy in Focus: What Early Payer Decisions Signal f...
NovoCare and the Rise of Direct-to-Consumer Pharmaceutical Access
CMS Price Negotiations: Bridging the Gap in US Drug Pricing
Access to Anti-Obesity Medication for Medicare and Medicaid
Sanofi’s 340B Rebate Model: A Joint Effort to Reform Drug Pricing Pract...
Lawsuits Challenge 340B Drug Pricing Program: Eli Lilly and J&J vs. HRSA
CTO-PCI Technology for Heart Health in Egypt
Impact of Health Insurance on Advanced Prostate Cancer Treatment Costs
Transforming Value-Based Oncology Care: A Multifaceted Approach
Bupa Launches Whole Genome Sequencing Pilot in UK
Soaring Drug Prices in Europe: A Strain on Health Systems and Industry
« Previous
1
…
3
4
5
6
7
…
11
Next »